ARTICLE | Company News
FDA approves Gablofen for spasticity
November 24, 2010 1:10 AM UTC
FDA approved an NDA from CNS Therapeutics Inc. (St. Paul, Minn.) for Gablofen baclofen injection to manage severe spasticity. The application was submitted under section 505(b)(2) of the Food, Drug an...